BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15258425)

  • 1. Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mRNAs in the liver and changes in serum lipids.
    Araki S; Okazaki M; Goto S
    Gerontology; 2004; 50(4):206-15. PubMed ID: 15258425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary restriction in aged mice can partially restore impaired metabolism of apolipoprotein A-IV and C-III.
    Araki S; Goto S
    Biogerontology; 2004; 5(6):445-50. PubMed ID: 15609108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-associated changes in the serum level of apolipoproteins A-I and A-IV and the gene expression as revealed by fasting and refeeding in mice.
    Araki S; Goto S
    Exp Gerontol; 2003 May; 38(5):499-506. PubMed ID: 12742527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of feeding diets of varying fatty acid composition on apolipoprotein expression in newborn swine.
    Wang H; Hunter F; Black DD
    Am J Physiol; 1998 Oct; 275(4):G645-51. PubMed ID: 9756492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.
    Qi K; Fan C; Jiang J; Zhu H; Jiao H; Meng Q; Deckelbaum RJ
    Clin Nutr; 2008 Jun; 27(3):424-30. PubMed ID: 18362042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver.
    Song W; Chen J; Redinger RN
    J Investig Med; 1998 Dec; 46(9):460-9. PubMed ID: 9861782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation.
    Navarro MA; Carpintero R; Acín S; Arbonés-Mainar JM; Calleja L; Carnicer R; Surra JC; Guzmán-García MA; González-Ramón N; Iturralde M; Lampreave F; Piñeiro A; Osada J
    Cytokine; 2005 Jul; 31(1):52-63. PubMed ID: 15878672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
    VerHague MA; Cheng D; Weinberg RB; Shelness GS
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency.
    Garenc C; Couillard C; Laflamme N; Cadelis F; Gagné C; Couture P; Julien P; Bergeron J
    Eur J Hum Genet; 2005 Oct; 13(10):1159-65. PubMed ID: 16015281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in lipid components in the adipose and liver tissues of regucalcin transgenic rats with increasing age: suppression of leptin and adiponectin gene expression.
    Yamaguchi M; Nakagawa T
    Int J Mol Med; 2007 Sep; 20(3):323-8. PubMed ID: 17671736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
    Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake.
    Lichtenstein L; Berbée JF; van Dijk SJ; van Dijk KW; Bensadoun A; Kema IP; Voshol PJ; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2420-7. PubMed ID: 17761937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro transfer of apolipoproteins from plasma lipoproteins to artificial lipid particles.
    Asami H; Iriyama K
    Nutrition; 1990; 6(2):143-5. PubMed ID: 2134526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.
    Kuipers F; Jong MC; Lin Y; Eck M; Havinga R; Bloks V; Verkade HJ; Hofker MH; Moshage H; Berkel TJ; Vonk RJ; Havekes LM
    J Clin Invest; 1997 Dec; 100(11):2915-22. PubMed ID: 9389759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
    Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
    Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
    Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
    Andersson Y; Majd Z; Lefebvre AM; Martin G; Sechkin AV; Kosykh V; Fruchart JC; Najib J; Staels B
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):115-21. PubMed ID: 9888873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.